Background One third of patients presenting with initially mild strokes have unfavorable
outcomes, and the efficacy of intravenous thrombolysis (IVT) in this population has not been …

Importance Mild strokes have been poorly represented in thrombolytic trials and only a few
series have reported outcomes after treatment with intravenous (IV) recombinant tissue …

Background Optimal treatment strategy in patients with mild ischemic stroke remains
uncertain. While functional dependency or death has been reported in up to one-third of non …

Background Mild stroke accounts for more than a half of all stroke patients, and short-term
outcomes after treatment with intravenous (IV) recombinant tissue plasminogen activator …

Objective: This study assessed the characteristics of intravenous thrombolysis (IVT) with
respect to early neurological deterioration (END) and functional outcome in mild ischemic …

BACKGROUND: Current guidelines do not define the lower severity threshold for
thrombolysis. In this study, we describe the variability of treatment of mild stroke patients …

Background Up to 30% of stroke patients initially presenting with non-disabling or mild
deficits may experience poor functional outcome. Despite, intravenous thrombolysis remains …

Background and purpose Recent cross‐sectional study data suggest that intravenous
thrombolysis (IVT) in patients with in‐hospital stroke (IHS) onset is associated with …

Little is known about intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) patients
with pre-existing disability. Disabled patients are often excluded from IVT treatment …

Purpose Intravenous thrombolysis (IVT) has become a standard treatment for eligible
ischemic stroke patients. However, functional outcomes after receiving IVT varied widely …